Evidence map›Paper›PMID 16704776›Full record

ArticleEmerging infectious diseases2006

Aspergillus ustus infections among transplant recipients.

Anil A Panackal, Alexander Imhof, Edward W Hanley, Kieren A Marr

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Case reports in infectious diseases · 2025
    Article
  2. Article
  3. Review
  4. Clinical Relevance and Characteristics ofJournal of fungi (Basel, Switzerland) · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Treatment options in Invasive Aspergillosis.Current treatment options in infectious diseases · 2014
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. New taxa in Aspergillus section Usti.Studies in mycology · 2011
    Article
  16. Review
  17. Cutaneous model of invasive aspergillosis.Antimicrobial agents and chemotherapy · 2010
    Article
  18. Article
  19. Cerebral aspergillosis caused by Aspergillus granulosus.Journal of clinical microbiology · 2009
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anil A PanackalFred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Alexander Imhof
Edward W Hanley
Kieren A Marr

Funding

Antifungal Drug Resistance in AspergillusR21AI055928 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MARR, KIEREN A. · 2003 to 2004
$507k
NIAID NIH HHS R21 AI055928NIAID NIH HHS R21 AI55928
6 · The paper itself

Abstract

Aspergillus ustus is a mold that rarely infects humans; only 15 systemic cases have been reported. We report the first outbreak of invasive infection caused by A. ustus among hematopoietic stem cell transplant (HSCT) recipients. Six patients with infections were identified; 3 infections each occurred in both 2001 and 2003. Molecular typing by using randomly amplified polymorphic DNA (RAPD) and antifungal drug susceptibility testing were performed on clinical and environmental isolates recovered from our hospital from 1999 to 2003. The highest overall attack rate in HSCT patients was 1.6%. The overall death rate was 50%, and death occurred within 8 days after diagnostic culture collection. Clinical isolates exhibited decreased susceptibility to antifungal drugs, especially azoles. RAPD and phylogenetic analysis showed genetic similarity between isolates from different patients. Based on the clustering of cases in space and time and molecular data, common-source acquisition of this unusual drug-resistant species is possible.

Indexed as

AdultAntifungal AgentsAspergillosisAspergillusDisease OutbreaksFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedPhylogenyAntifungal Agents

Identifiers

PMID16704776
PMCPMC3291436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.